Homocysteine in Relation to Mortality and Morbidity From Coronary Heart Disease – (02-16-04)

Homocysteine in Relation to Mortality and Morbidity From Coronary Heart Disease

Don’t quite hold your breath yet waiting for mainstream medicine to start running standard homocysteine levels. A 5x increase risk of fatal MI and a very cheap and safe method to lower levels (not to mention benefits across other disease states) does not mean we should check levels. Personally, I’m going to wait another 20 or so years until the evidence is so stacked in favor of checking homocysteine levels that we actually see to stories in our local newspapers’ health section. THEN will be the appropriate time to start checking.

Circulation — Abstracts: Zylberstein et al. 109 (5): 601 –

Read entire article here

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email: